Arrhythmias & EP
From the Journals
Stroke risk in new-onset atrial fib goes up with greater alcohol intake
That increasing risk, which is independent of oral anticoagulation, may attenuate or disappear in patients who give up drinking after their AF...
From the Journals
Reversal agents curb DOAC-related bleeding but deaths still high
The meta-analysis of more than 4,000 patients also showed thrombotic events were more frequent with andexanet than with 4PCC or idarucizumab.
From the Journals
Are left atrial thrombi that defy preprocedure anticoagulation predictable?
Features that predispose to such persistent LA thrombi, which are not very rare, could potentially guide more targeted TEE screening before rhythm...
From the Journals
Evidence builds for iPhone 12 interference with cardiac devices
Greater public awareness is needed, as are further studies to confirm the results, including differences in susceptibility among devices, the...
From the Journals
Revised dispatch system boosts bystander CPR in those with limited English
Lack of English proficiency was less of a barrier to bystander CPR in Los Angeles after a simplified, tiered dispatch system was put in place.
News
In-hospital resuscitation: Focus on effective chest pumps, prompt shocks
Consider mechanical piston compressions and even “reverse CPR” when appropriate.
From the Journals
Heart benefits of DASH low-sodium diet ‘swift and direct’
A study for the first time shows that combining the DASH diet with sodium restriction lowers myocardial injury and strain, two strong correlates...
Conference Coverage
Benefit from cooling temps for cardiac arrest does not differ in randomized trial
For major outcomes, cooling comatose cardiac arrest patients to 31° had no advantage over 34° in a controlled trial.
From the Journals
Underlying heart rhythm, not ICD shocks, drives mortality
Survival after implantable cardioverter-defibrillator shocks depends more on the nature of the underlying arrhythmic substrate than on any adverse...
Conference Coverage
FIDELIO-DKD: Finerenone cuts new-onset AFib in patients with type 2 diabetes and CKD
Conference Coverage
New STRENGTH analysis reignites debate on omega-3 CV benefits
The new analysis showing no benefits linked to higher achieved levels of EPA casts doubt over the use of high-dose omega-3 fatty acid products for...